Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00005650 · ClinicalTrials.gov registry record

Genetic Study of Patients With Primary Ciliary Dyskinesia

A clinical trial, sponsored by National Center for Research Resources (NCRR).

Completed
Registry status
180
Enrollment target

NCT00005650: Completed study, sponsored by National Center for Research Resources (NCRR).

NCT00005650 is a clinical trial that has completed, run by National Center for Research Resources (NCRR). The registered enrollment target is 180 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00005650 has completed, sponsored by National Center for Research Resources (NCRR).

COMPLETED
Registry status
180 participants
Enrollment target

Study Summary

OBJECTIVES: I. Characterize the clinical presentation of patients with primary ciliary dyskinesia. II. Identify the genetic mutations associated with this disease.

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2000-02

What the finished NCT00005650 record still lists

NCT00005650 is an observational study that tracks outcomes without assigning an intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00005650 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00005650 about?

NCT00005650 is a clinical study titled "Genetic Study of Patients With Primary Ciliary Dyskinesia". OBJECTIVES: I. Characterize the clinical presentation of patients with primary ciliary dyskinesia. II. Identify the genetic mutations associated with this disease.

What is the current status of trial NCT00005650?

This trial is currently completed. The enrollment target is 180 participants. The study started on 2000-02.

Who is sponsoring clinical trial NCT00005650?

This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01558804 · 180 participants

    GRoup A StrePtococcus

  • NCT02932176 · 180 participants

    Machine Learning for Handheld Vascular Studies

  • NCT03384563 · 180 participants · Phase 4

    Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane

  • NCT03423628 · 180 participants · Phase 1

    A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00005650, the US trial registry maintained by the National Library of Medicine. NCT00005650 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.